Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that it has entered into a non-binding Memorandum of Understanding (“MOU” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback